Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Cellectis S.A.
  6. News
  7. Summary
    ALCLS   FR0010425595

CELLECTIS S.A.

(ALCLS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Higher in Monday Trading

08/02/2021 | 11:14am EDT


ę MT Newswires 2021
All news about CELLECTIS S.A.
09/21CALYXT, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibi..
AQ
09/16European ADRs Move Lower in Thursday Trading
MT
09/10European ADRs Move Higher in Friday Trading
MT
09/09European ADRs Move Lower in Thursday Trading
MT
09/01European ADRs Move Higher in Wednesday Trading
MT
08/27European ADRs Rise Nearly 1% Friday Morning
MT
08/27GLOBAL MARKETS LIVE : Nvidia, Microsoft, Dell, Apple, Uber...
08/27CELLECTIS S A : Announces Participation in Five Investor Conferences (Form 6-K)
PU
08/26Cellectis Announces Participation in Five Investor Conferences
GL
08/23European ADRs Move Higher in Monday Trading
MT
More news
Analyst Recommendations on CELLECTIS S.A.
More recommendations
Financials
Sales 2021 74,7 M 87,5 M 87,5 M
Net income 2021 -97,6 M -114 M -114 M
Net cash 2021 139 M 163 M 163 M
P/E ratio 2021 -5,59x
Yield 2021 -
Capitalization 526 M 616 M 617 M
EV / Sales 2021 5,18x
EV / Sales 2022 6,09x
Nbr of Employees 277
Free-Float 84,4%
Chart CELLECTIS S.A.
Duration : Period :
Cellectis S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CELLECTIS S.A.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 11,58 €
Average target price 22,25 €
Spread / Average Target 92,1%
EPS Revisions
Managers and Directors
AndrÚ Choulika Chief Executive Officer & Director
Eric Dutang Chief Financial Officer
Jean-Pierre Garnier Non-Executive Chairman
Philippe Duchateau Chief Scientific Officer
Francisco J. Esteva Vice President-Clinical Development
Sector and Competitors
1st jan.Capi. (M$)
CELLECTIS S.A.-52.54%616
MODERNA, INC.311.74%173 624
LONZA GROUP AG30.56%59 611
IQVIA HOLDINGS INC.46.01%50 128
CELLTRION, INC.-23.54%31 745
SEAGEN INC.-7.88%29 353